在NSCLC中使用mTOR信号:机制和治疗前景
Antonios N Gargalionis1, Kostas A Papavassiliou2, Athanasios G Papavassiliou3
1Department of Biopathology, 'Eginition' Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
在非小细胞肺癌 (NSCLC) 中准拉巴胺素 (mTOR) 途径的机械标是具有挑战性的. 本综述探讨了mTOR信号机制和NSCLC的治疗策略,旨在改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症信号传递 癌症信号传递
背景情况:
- 拉巴胺素 (mTOR) 途径的机械性标是细胞生存和新陈代谢的关键调节者.
- 异常的mTOR激活与各种癌症有关,包括非小细胞肺癌 (NSCLC).
- 目前针对NSCLC中mTOR途径的治疗策略已经产生了不令人满意的临床结果.
研究的目的:
- 审查最近关于NSCLC中mTOR信号机制的发现.
- 讨论NSCLC中mTOR网络治疗向的挑战和潜力.
- 探索在NSCLC中有效的mTOR向治疗的未来前景.
主要方法:
- 关于NSCLC中mTOR信号传递的最近研究的文献综述.
- 分析mTOR途径组件在NSCLC发育中的致癌作用.
- 在NSCLC中对mTOR向治疗的临床试验结果的评估.
主要成果:
- 增加mTOR通路激活是NSCLC的一个常见的瘤特征.
- mTOR失调有助于NSCLC的特征:瘤发生,亡抵抗,血管发生和转移.
- 目前mTOR抑制剂在NSCLC的临床疗效仍然有限.
结论:
- 了解mTOR网络的复杂性对于NSCLC治疗至关重要.
- 需要新的治疗策略来克服针对NSCLC的mTOR的挑战.
- 未来的研究应该专注于优化mTOR相关疗法,以改善患者的治疗结果.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
